Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Oklahoma | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to assess the feasibility of using interactive teaching to educate cervical cancer patients about Human papillomavirus (HPV) and HPV vaccinations.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control | Active Comparator | The control group will be given a standardized handout |
|
| Intervention | Experimental | The intervention group will be shown an educational video |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Control | Other | A standardized handout on HPV and vaccine education will be given |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Participation Rate | The Ratio of the number of participants to the number of patients asked to join the clinical trial | Up to 6 weeks |
| Survey Completion Rate | The Ratio of the number of participants who complete the survey to the number of participants overall. | Up to 6 Weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Change in intention to discuss HPV vaccination | Changes from pre to post/follow up on intervention survey | Up to 6 weeks |
| Change in Health Literacy | Changes in knowledge of HPV virus and prevention from pre to post/follow up survey |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Radhika Gogoi, M.D. PhD | Karmanos Cancer Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | ||
| University of Oklahoma Health Sciences Center |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Jun 18, 2021 | Jul 31, 2024 | Prot_SAP_000.pdf |
| ICF | No | No | Yes | Informed Consent Form | Oct 12, 2021 | Jul 31, 2024 | ICF_001.pdf |
Not provided
| ID | Term |
|---|---|
| D002583 | Uterine Cervical Neoplasms |
| D014625 | Vaginal Neoplasms |
| D014846 | Vulvar Neoplasms |
| ID | Term |
|---|---|
| D014594 | Uterine Neoplasms |
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
Not provided
Not provided
| ID | Term |
|---|---|
| D008722 | Methods |
| ID | Term |
|---|---|
| D008919 | Investigative Techniques |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Intervention |
| Other |
A video about HPV and vaccines on a tablet provided by a research assistant |
|
| Up to 6 weeks |
| Change in social norms and behaviors | Changes in social norms and behavioral control measures from pre and post/follow-up survey | Up to 6 weeks |
| Change in Stigma | Changes in stigma measures in pre and post/follow up surveys | Up to 6 weeks |
| Oklahoma City |
| Oklahoma |
| 73104 |
| United States |
| D009369 |
| Neoplasms |
| D002577 | Uterine Cervical Diseases |
| D014591 | Uterine Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |
| D014623 | Vaginal Diseases |
| D014845 | Vulvar Diseases |